Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction

Atherosclerosis

Volumn 185, Issue 2, 2006, Pages 421-425

  Wierzbicki, Anthony S ^a   Solomon, Hemant ^a   Lumb, Peter J ^a   Lyttle, Kereese ^a   Lambert Hammill, Michelle ^a   Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Asymmetric dimethylarginine; Cardiovascular; Erectile dysfunction; Risk factor; Selectin; Sildenafil

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; SILDENAFIL;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ARGININE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; E-SELECTIN; ENZYME INHIBITORS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PIPERAZINES; RISK FACTORS;

EID: 33644514607     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.06.025     Document Type: Article

References (34)

1. H. Solomon, J.W. Man, and G. Jackson Erectile dysfunction and the cardiovascular patient endothelial dysfunction is the common denominator Heart 89 3 2003 251 253
2. H. Solomon, J. Man, A.S. Wierzbicki, T. O'Brien, and G. Jackson Erectile dysfunction: cardiovascular risk and the role of the cardiologist Int J Clin Pract 57 2 2003 96 99
3. H. Solomon, J.W. Man, A.S. Wierzbicki, and G. Jackson Relation of erectile dysfunction to angiographic coronary artery disease Am J Cardiol 91 2 2003 230 231
4. A.S. Wierzbicki, P.J. Chowienczyk, and J.R. Cockcroft Cardiovascular risk factors and endothelial dysfunction Clin Sci (London) 107 6 2004 609 615
5. R.H. Boger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 4 2003 824 833
6. V.P. Valkonen, H. Paiva, and J.T. Salonen Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 9299 2001 2127 2128
7. P. Vallance, and J. Leiper Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway Arterioscler Thromb Vasc Biol 24 6 2004 1023 1030
8. J.T. Kielstein, J.C. Frolich, H. Haller, and D. Fliser ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? Nephrol Dial Transplant 16 9 2001 1742 1745
9. R.H. Boger Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data Dtsch Med Wochenschr 129 15 2004 820 824
10. R. Schiel, S. Franke, and M. Busch Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency Eur J Med Res 8 7 2003 283 291
11. T.M. Lu, Y.A. Ding, S.J. Lin, W.S. Lee, and H.C. Tai Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24 21 2003 1912 1919
12. R. Maas, E. Schwedhelm, J. Albsmeier, and R.H. Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vasc Med 7 3 2002 213 225
13. R.C. Rosen, A. Riley, and G. Wagner The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822 830
14. P.J. Chowienczyk, R.P. Kelly, and H. MacCallum Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus J Am Coll Cardiol 34 7 1999 2007 2014
15. S.C. Millasseau, F.G. Guigui, and R.P. Kelly Noninvasive assessment of the digital volume pulse Comparison with the peripheral pressure pulse Hypertension 36 6 2000 952 956
16. S.C. Millasseau, R.P. Kelly, J.M. Ritter, and P.J. Chowienczyk Determination of age-related increases in large artery stiffness by digital pulse contour analysis Clin Sci (London) 103 4 2002 371 377
17. R. Maas, E. Schwedhelm, J. Albsmeier, and R.H. Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vasc Med 7 3 2002 213 225
18. M. Bocchio, G. Desideri, and P. Scarpelli Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage J Urol 171 4 2004 1601 1604
19. K. Sydow, and T. Munzel ADMA and oxidative stress Atheroscler Suppl 4 4 2003 41 51
20. C.L. Smith, G.M. Birdsey, and S. Anthony Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype Biochem Biophys Res Commun 308 4 2003 984 989
21. V.P. Valkonen, J. Laakso, and H. Paiva Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events Does statin treatment influence plasma ADMA levels? Atheroscler Suppl 4 4 2003 19 22
22. H. Paiva, J. Laakso, and T. Lehtimaki Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors J Cardiovasc Pharmacol 41 2 2003 219 222
23. J. Dierkes, S. Westphal, J. Martens-Lobenhoffer, C. Luley, and S.M. Bode-Boger Fenofibrate increases the l-arginine:ADMA ratio by increase of l-arginine concentration but has no effect on ADMA concentration Atherosclerosis 173 2 2004 239 244
24. T. Janatuinen, J. Laakso, and R. Laaksonen Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults Vasc Med 8 3 2003 185 189
25. H. Paiva, J. Laakso, and H. Laine Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia J Am Coll Cardiol 40 7 2002 1241 1247
26. A.S. Wierzbicki Lipid lowering: another method of reducing blood pressure? J Hum Hypertens 16 11 2002 753 760
27. H.A. Walker, E. McGing, and I. Fisher Endothelium-dependent vasodilation is independent of the plasma l-arginine/ADMA ratio in men with stable angina: lack of effect of oral l-arginine on endothelial function, oxidative stress and exercise performance J Am Coll Cardiol 38 2 2001 499 505
28. N.N. Chan, and J.C. Chan Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 45 12 2002 1609 1616
29. C. Fleck, F. Schweitzer, E. Karge, M. Busch, and G. Stein Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases Clin Chim Acta 336 1-2 2003 1 12
30. R.H. Boger, and S.M. Bode-Boger Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases Semin Thromb Hemost 26 5 2000 539 545
31. C. Zoccali, F. Mallamaci, and R. Maas Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients Kidney Int 62 1 2002 339 345
32. C. Zoccali, F.A. Benedetto, and R. Maas Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease J Am Soc Nephrol 13 2 2002 490 496
33. H.M. Eid, H. Arnesen, E.M. Hjerkinn, T. Lyberg, and I. Seljeflot Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine Metabolism 53 12 2004 1574 1579
34. R. Maas, and R.H. Boger Old and new cardiovascular risk factors: from unresolved issues to new opportunities Atheroscler Suppl 4 4 2003 5 17